Eli Lilly, hospitals go to war over drug prices

coapharm2020-10-08T14:14:44+00:00October 8, 2020|

Black Patients With Cancer May Be at Increased Risk for Hospitalization Related to COVID-19 Infection

coapharm2020-10-07T13:06:05+00:00October 7, 2020|

The Booming Biosimilar Market of 2020

coapharm2020-10-06T13:58:18+00:00October 6, 2020|

Supreme Court to review contentious state law governing pharmacy benefit managers

coapharm2020-10-06T13:55:18+00:00October 6, 2020|

Big fight over drug pricing heads to the Supreme Court

coapharm2020-10-05T14:26:48+00:00October 5, 2020|

Court’s newest ERISA dispute will clarify states’ authority to regulate prescription-drug middlemen

coapharm2020-10-05T14:25:54+00:00October 5, 2020|

Drugs aren’t the reason the U.S. spends so much on health care

coapharm2020-09-30T13:56:10+00:00September 30, 2020|

Trump Doesn’t Need Price Controls to Lower Prescription Drug Costs

coapharm2020-09-30T13:55:24+00:00September 30, 2020|

A Year of Living Dangerously: 2020 and Maneuvers on the 340B Drug Pricing Program Battlefield

coapharm2020-09-30T13:54:33+00:00September 30, 2020|

Royal Oak lawmakers sound warning against Beaumont hospital merger

coapharm2020-09-30T13:53:52+00:00September 30, 2020|